These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22292808)

  • 1. Tumour-specific uptake of anti-cancer drugs: the future is here.
    Caraglia M; Marra M; Misso G; Lamberti M; Salzano G; De Rosa G; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):4-21. PubMed ID: 22292808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
    Wang J; Sui M; Fan W
    Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
    Oku N
    Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeting of drug delivery systems to cancer.
    Minko T; Dharap SS; Pakunlu RI; Wang Y
    Curr Drug Targets; 2004 May; 5(4):389-406. PubMed ID: 15134222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.
    Cegnar M; Kristl J; Kos J
    Expert Opin Biol Ther; 2005 Dec; 5(12):1557-69. PubMed ID: 16318420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
    Maruyama K
    Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.
    Sakurai Y; Kajimoto K; Harashima H
    Biomater Sci; 2015 Sep; 3(9):1253-65. PubMed ID: 26261854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive and active tumour targeting with nanocarriers.
    Hirsjärvi S; Passirani C; Benoit JP
    Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
    Sengupta S; Eavarone D; Capila I; Zhao G; Watson N; Kiziltepe T; Sasisekharan R
    Nature; 2005 Jul; 436(7050):568-72. PubMed ID: 16049491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology: a focus on nanoparticles as a drug delivery system.
    Kingsley JD; Dou H; Morehead J; Rabinow B; Gendelman HE; Destache CJ
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):340-50. PubMed ID: 18040810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.